Phone E-Mail

RECENT NEWS

  • January 26, 2020 Dr. Fernando Muzzio provides testimony on advanced pharmaceutical manufacturing and on drug shortages in front of the Health Subcommittee of the US House of Representatives • Opening statement • Full hearing • Document

  • July 13, 2018 Dr. Muzzio and C-SOPS received Chairman award from the Research and development council of New Jersey. Read more

  • August 20, 2017 Want to cut healthcare costs? Try automation, Dr. Fernando J. Muzzio, opinion contributor in THE HILL. Download the article.

VIEW ALL NEWS

Acumen technical notes

■We are posting a series of articles describing different ways to perform pharmaceutical product and ingredient testing that are relevant to a wide range of litigation and prosecution issues.

■Find the first three here, focusing on the role of drug release testing (dissolution testing), viscosity testing, and tablet hardness testingon patent litigation and prosecution. You and your colleagues might find this useful.

Case Study

Viscosity Testing primer


View More
Expert Witness

Dissolution Testing primer


View More
Pharma Manufacture

Tablet Hardness Testing primer


View More

 

Acumen BioPharma’s competitive advantage
 

  • A strong network of top academic and industry scientists in pharmaceutical design, development and manufacturing technology
  • World-leading research programs in pharmaceutical processing, pharmaceutical manufacturing, pharmaceutical powder technology, and other critical topics
  • Established contractual relationships with academic institutions allow our clients fast access to comprehensive state of the art laboratory technologies and highly trained scientists to develop and execute the scientific tests and measurements required to support testimony rationale and provide scientific evidence in support of litigation argument
  • An established track record of excellence
  • Substantial experience, including highly visible recent litigation in federal court (see recent case studies)
  • A strong established relationship with the FDA. Our academic consultants serve in technical committees, are funded by the FDA to perform research and training in support of regulatory functions, and are frequent lecturers at FDA-sponsored events.

 

 

Inquire Now


FROM OUR CLIENTS

  • “Acumen BioPharma has been instrumental for my practice in intellectual property litigation in the identification of cutting edge technology to conduct scientific analysis. Acumen's process emphasizes detailed coordination focused on customer deadlines.”
    - Patent Litigator, Washington DC
  • “As a patent litigator involved in Hatch Waxman related cases, I have been very satisfied with the excellence of services and consistent timely delivery received from Acumen BioPharma.  Acumen brings together top scientists from different disciplines in pharmaceutical manufacturing technology to conduct in-depth scientific assessment of patents and provide technical advice based on solid scientific grounds.  ”
    - Patent litigator, California based law firm
  • “ In my patent litigation practice, Acumen has consistently been able to provide excellent technical advice, comprehensive laboratory testing services (including re-creation of critical prior art examples) and has done so on very challenging timelines.”
    - Patent litigator, major New York area law firm
    • ❚❚